William Chin

[William Chin @will_iamchin]

Moving toward a paradigm shift in the regulatory requirements for pediatric medicines #pediatrics https://t.co/IcREAs7Ha7

[William Chin @will_iamchin]

Sharing is caring...or is it really so? https://t.co/IBladCZnBX

[William Chin @will_iamchin]

#PLOSBiology: Ethics Reporting in Biospecimen and Genetic Research: Current Practice and Suggestions for Changes https://t.co/CopSExjoSB

[William Chin @will_iamchin]

EMA statement on the outcome of the UK referendum
https://t.co/q2BVyyf8eS

[William Chin @will_iamchin]

And the finger pointing starts now...France faults Bial and Biotrial over fatal drug trial https://t.co/n7on19lZiF via @Reuters

[William Chin @will_iamchin]

Transparency of risk-benefit assessment in the Bial trial is important for future early trials https://t.co/vKN43LU2Nx

[Meg Tirrell @megtirrell]

Harvard Public Health Review: Olympics must be moved or postponed because of #Zika https://t.co/bffttiqLVd

[William Chin @will_iamchin]

Drug industry warns of effects of British EU departure https://t.co/CKzw8qIRZd

[William Chin @will_iamchin]

Congrats @Official_EMWA team! Clarity & openness in reporting of clinical study reports. Open access publication:
https://t.co/e7AXk5i1MV

[William Chin @will_iamchin]

The quiet revolutionary: Emmanuelle Charpentier’s life https://t.co/Q2rkmrze3Z via @rightrelevance thanks @edyong209

[William Chin @will_iamchin]

Involving general practitioners in regulatory decisions on medicines https://t.co/TRS6goNR9N

[William Chin @will_iamchin]

EMA - "Vaccinated salmon are safe to eat".https://t.co/f7xSGURr32

[William Chin @will_iamchin]

EMA and EUnetHTA Release Collaboration Report https://t.co/DZZmYj59Bj

[William Chin @will_iamchin]

5 Reasons Why Young Professionals Should Attend the 28th DIA EuroMeeting in Hamburg, Germany https://t.co/loRgwVwdIM

[William Chin @will_iamchin]

@EMA_News thanks for the reply. much appreciated!

[William Chin @will_iamchin]

@EMA_News It has been more than a week that the trial with Bial drug was halted. Why is there no official statement from EMA?

[William Chin @will_iamchin]

Déjà vu??? Another Tenegero incident? https://t.co/pVFDCEc3GY

[William Chin @will_iamchin]

Which drugs are going off-patent in 2016? https://t.co/YebomYdMr2

[William Chin @will_iamchin]

"Considerations and regulatory affairs for research in special population " by @will_iamchin on @LinkedIn https://t.co/HvsMxYQ9Ll